Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial.
| Author | |
|---|---|
| Abstract |
:
Central line-associated bloodstream infections (CLABSIs) affect about 25% of children with cancer, and treatment failure is common. Adjunctive ethanol lock therapy might prevent treatment failure but high-quality evidence is scarce. We evaluated ethanol lock therapy as treatment and secondary prophylaxis for CLABSI in children with cancer or haematological disorders. |
| Year of Publication |
:
2018
|
| Journal |
:
The Lancet. Infectious diseases
|
| Volume |
:
18
|
| Issue |
:
8
|
| Number of Pages |
:
854-863
|
| ISSN Number |
:
1473-3099
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(18)30224-X
|
| DOI |
:
10.1016/S1473-3099(18)30224-X
|
| Short Title |
:
Lancet Infect Dis
|
| Download citation |
